Timothy Alexander

Frontline Expands AI Initiatives for K-12 School Systems WAYNE, PA — Frontline Education announced new artificial intelligence initiatives, including an advisory council, a partnership, and expanded product f […]

Madrigal to Report Q1 2026 Results May 6, Host Webcast CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) will release its first-quarter 2026 financial results on Wednesday, May 6, 2026, b […]

SEED Reports Preclinical Data on RBM39 Drug in Neuroblastoma KING OF PRUSSIA, PA — SEED Therapeutics, Inc. reported new preclinical data showing anticancer activity of its RBM39 degrader candidate ST-01156 in n […]

NRx Reports FDA Feedback, Progress on Ketamine Application WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently received a Discipline Review Letter from the U.S. Food and Drug Administration i […]

Market Better Acquires Legacy Media, Launches Studio Unit BRYN MAWR, PA — Market Better has acquired Legacy Media and launched Market Better Studio, a new business unit focused on providing marketing s […]

Toll Brothers to Acquire Buffington Homes of Arkansas Assets FORT WASHINGTON, PA — Toll Brothers, Inc. (NYSE: TOL) recently signed a definitive agreement to acquire substantially all the assets of Buffington H […]

Charlton Aria Receives Nasdaq Notice Over Late 10-K Filing WILMINGTON, DE — Charlton Aria Acquisition Corporation (Nasdaq: CHARU) recently received a notice from Nasdaq stating it is not in compliance with l […]

From Asylum to Open Space: The Quiet Evolution of Embreeville The water bends before you see it, the sound arriving first—a low, steady rush slipping over stone and settling into something quieter as it curves t […]

Madrigal Grants Equity Awards to 12 New Employees CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) recently granted equity inducement awards to 12 new non-executive employees on April 1 […]

TELA Bio Schedules Q1 2026 Earnings Release and Call MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will report its first-quarter 2026 financial results on Tuesday, May 12, 2026, and will host a conference c […]

Gaming and Leisure Properties Reports First-Quarter Results WYOMISSING, PA — Gaming and Leisure Properties, Inc. (Nasdaq: GLPI) recently reported financial results for the quarter ended March 31, 2026, showing i […]

Aprea Abstract Accepted for ASCO on APR-1051 Phase 1 Study DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) will present early results from a Phase 1 clinical trial of its WEE1 inhibitor APR-1051 at t […]

NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) recently closed its previously announced license and acquisition of a portfolio of regenerative b […]

Neuronetics Schedules Q1 2026 Earnings Release and Call MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) plans to release its first-quarter 2026 financial and operating results before market open on Tuesday, M […]

Savara Grants Equity Awards to 24 New Employees LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) recently granted equity inducement awards to 24 newly hired employees on April 14, 2026, under its 2021 I […]

Radian Group to Report First-Quarter Results, Host May 7 Call WAYNE, PA — Radian Group Inc. (NYSE: RDN) will report its first-quarter 2026 results after market close on Wednesday, May 6, and will host a c […]

South Street Transforms for Brauhaus Schmitz Maifest Block Party PHILADELPHIA, PA — South Street will burst into music, dancing, and old-world tradition as Brauhaus Schmitz brings back its annual Maifest, turning t […]

Uplynk Reports Growth, Expands AI and Streaming Services Strategy WILMINGTON, DE — Uplynk recently reported positive financial performance in its first fiscal year as a standalone company, including a double-digit a […]

Clean Earth Launches Solar Panel Recycling at Texas Facility KING OF PRUSSIA, PA — Clean Earth, a division of Enviri Corporation (NYSE: NVRI), has launched solar panel recycling services at its Lancaster, T […]

Passage Bio Reports Trial Data, Reviews Strategic Options PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) reported recently updated clinical data for its PBFT02 therapy in frontotemporal dementia and s […]